Biogen Inc.
Location
Massachusetts
Founded
1978-02-28
Website
Risk Signals
6605 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Pharmaceutical Preparations, Biological Products, Except Diagnostic Substances, Commercial Physical and Biological Research), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about Biogen Inc.
Live alerts from global media, monitored by Business Radar
2025-02-12 (elpais.com)
Pharmaceuticals commit themselves to Sanchez to multiply their investment if it is encouraged | Companies |
Sector companies plan to close this year with 9,000 million investment in three years in Spain
Read more
2025-01-24 (mmm-online.com)
Rx Rundown: AbbVie, Purdue Pharma, HHS and more - MM+M - Medical Marketing and Media
Check out this week’s medical marketing news, dealmaking and industry chatter.
Read more
2025-01-20 (edisongroup.com)
BB Biotech — A positive start to a promising year -
BB Biotech (BION) is the largest biotech investor among its investment company peers.
Read more
2025-01-18 (benzinga.com)
Deal Dispatch: Biden Punts TikTok Ban To Trump, Fate Hangs — Another Private Equity Owned Retailer Goes Bankrupt - AbbVie (NYSE:ABBV), Biogen (NASDAQ:BIIB) -
Deal opportunities abound: KKR & Co.'s stake in Maya; DuPont's electronics business; Ingevity's North Charleston site; and S&W Seed Company.
Read more
2024-12-12 (marketbeat.com)
Saratoga Research & Investment Management Cuts Stake in Biogen Inc. (NASDAQ:BIIB)
Saratoga Research & Investment Management lessened its holdings in shares of Biogen Inc. (NASDAQ:BIIB - Free Report) by 4.5% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 150,720 shares of
Read more
2024-12-07 (etfdailynews.com)
Public Sector Pension Investment Board Boosts Stake in Biogen Inc. (NASDAQ:BIIB) -
Read Public Sector Pension Investment Board Boosts Stake in Biogen Inc. (NASDAQ:BIIB) at ETF Daily News
Read more
2024-10-10 (etfdailynews.com)
Sanctuary Advisors LLC Invests $1.39 Million in Biogen Inc. (NASDAQ:BIIB)
Sanctuary Advisors LLC acquired a new position in shares of Biogen Inc. (NASDAQ:BIIB – Free Report) in the second quarter, HoldingsChannel reports. The fund acquired 5,981 shares of the biotechnology company’s stock, valued at approximately $1,387,000.
Read more
2024-09-30 (marketbeat.com)
Saratoga Research & Investment Management Sells 5,060 Shares of Biogen Inc. (NASDAQ:BIIB)
Saratoga Research & Investment Management lessened its position in shares of Biogen Inc. (NASDAQ:BIIB - Free Report) by 3.1% in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 157,791 shares of the biotechnology c
Read more
2024-08-07 (alternativeswatch.com)
Sofinnova names Biogen CMO to investment team
Sofinnova Investments added Dr. Maha Radhakrishnan, former chief medical officer at Biogen, to its investment team as an executive partner.
Read more
2024-06-08 (defenseworld.net)
Capital World Investors Invests $8.85 Million in Biogen Inc. (NASDAQ:BIIB)
Read Capital World Investors Invests $8.85 Million in Biogen Inc. (NASDAQ:BIIB) at Defense World
Read more
2024-01-03 (e-fundresearch.com)
Xtrackers S&P 500 ETF 2C GBP | IE00BM67HX07 | e-fundresearch.com
Fund Rankings & Insights - Xtrackers S&P 500 ETF 2C GBP (IE00BM67HX07) - DWS Investment S.A. (ETF) - other equity funds and other equity funds in the fund ranking on e-fundresearch.com
Read more
2023-11-14 (finmarket.ru)
Investbank
Investment bank ``Sinara'' maintains ``hold'' rating for Tesla shares with outlook
Read more